Although it is unknown whether elevated WNT10B expression in PBMCs leads to additional lung parenchymal inflammation in TB patients, this research suggests that LINC00926 could serve as a potential TB biomarker and therapeutic target. Here, WNT10B is linked to tuberculosis.